THE IMMUNOVERSE Trademark
Trademark Overview
On Tuesday, May 7, 2024, a trademark application was filed for THE IMMUNOVERSE with the United States Patent and Trademark Office. The USPTO has given the THE IMMUNOVERSE trademark a serial number of 98537589. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 12, 2024. This trademark is owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.. The THE IMMUNOVERSE trademark is filed in the Education & Entertainment Services category with the following description:
Entertainment services, namely, providing podcasts in the field of immunotherapy
General Information
Serial Number | 98537589 |
Word Mark | THE IMMUNOVERSE |
Filing Date | Tuesday, May 7, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Tuesday, November 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
Goods and Services | Entertainment services, namely, providing podcasts in the field of immunotherapy |
Pseudo Mark | THE IMMUNO VERSE |
Classification Information
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, May 7, 2024 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | H. Lee Moffitt Cancer Center and Research Institute, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Tampa, FL 33612 |
Trademark Events
Event Date | Event Description |
Tuesday, May 7, 2024 | NEW APPLICATION ENTERED |
Monday, November 4, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, November 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 6, 2024 | ASSIGNED TO EXAMINER |
Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |